Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jad Chahoud"'
Autor:
Jacob J. Adashek, Yumeng Zhang, William Paul Skelton, Alyssa Bilotta, Jad Chahoud, Logan Zemp, Jiannong Li, Jasreman Dhillon, Brandon Manley, Philippe E. Spiess
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
BackgroundIt is highly contested whether cytoreductive nephrectomy for treating advanced renal cell carcinoma (RCC) with sarcomatoid features (sRCC) benefits overall survival. Patients with sRCC are known to have a poor prognosis, and these tumors ha
Externí odkaz:
https://doaj.org/article/b95b5bf74742483c8976461782277c39
Autor:
Jad Chahoud, William Paul Skelton, Philippe E. Spiess, Christine Walko, Jasreman Dhillon, Kenneth L. Gage, Peter A. S. Johnstone, Rohit K. Jain
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundPenile squamous cell carcinoma (PSCC) is a rare malignancy, and those patients with metastatic disease have limited treatment options. Treatment is largely comprised of platinum-based chemotherapy; however, patients progressing after initia
Externí odkaz:
https://doaj.org/article/7cc76ab044a34bcfa05c658d77010030
Autor:
Jasreman Dhillon, Yumeng Zhang, Alyssa Bilotta, Jad Chahoud, Philippe E. Spiess, William Paul Skelton, Brandon J. Manley, Logan Zemp, Jacob J. Adashek, Jiannong Li
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundIt is highly contested whether cytoreductive nephrectomy for treating advanced renal cell carcinoma (RCC) with sarcomatoid features (sRCC) benefits overall survival. Patients with sRCC are known to have a poor prognosis, and these tumors ha
Autor:
Jasreman Dhillon, Christine M. Walko, Kenneth L. Gage, Rohit Jain, William Paul Skelton, Jad Chahoud, Philippe E. Spiess, Peter A. S. Johnstone
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
BackgroundPenile squamous cell carcinoma (PSCC) is a rare malignancy, and those patients with metastatic disease have limited treatment options. Treatment is largely comprised of platinum-based chemotherapy; however, patients progressing after initia